Skip to main content

Why Systems-Level Thinking Is Essential in Modern Pharmaceutical Development

Why Modern Pharmaceutical Development Requires System Level Thinking? Challenges in Modern Pharmaceutical Development: The development of a drug product involves multiple interrelated factors that influence quality, safety, efficacy, and manufacturability. A change in one component (e.g., raw material, formulation composition, process parameter, etc.) can affect the critical quality attribute of the drug product.Therefore, the pharmaceutical development must consider the entire system and the interaction between the components. What is System-Level Thinking? Barry Richmond, a well-known...

Continue reading

Navigating the Key Challenges of Modern Pharmaceutical Development

WHY DO DEVELOPMENT CHALLENGES MATTER? Developing a successful pharmaceutical product requires more than scientific innovation. It demands careful planning, regulatory compliance, quality management, and cross-functional collaboration. Even promising products can face delays, increased costs, or failure if key challenges are not addressed early. 1.Inadequate Preformulation Studies Preformulation studies evaluate the physical and chemical properties of an Active Pharmaceutical Ingredient (API), including solubility, stability, polymorphism, hygroscopicity, pKa, and particle size Challenges Poor...

Continue reading

How Quality by Design (QbD) Improves Predictability in Pharmaceutical Development

QbD in Pharmaceutical Development Building Quality into Every Stage of Development Quality cannot be tested into a pharmaceutical product it must be designed into it from the very beginning. Quality by Design (QbD) is a systematic, science-based, and risk-driven approach that ensures quality is built into the product and manufacturing process from the earliest stages of development. Understanding the Product & Process By understanding the relationship between formulation variables, material attributes, and process parameters, QbD enables the development of robust products...

Continue reading

Why Formulation Strategy Determines Long-Term Pharmaceutical Product Success

Why Formulation Strategy Determines Long-Term Pharmaceutical Product Success Transforming Molecules Into Successful Medicines A promising drug molecule alone is not enough to ensure long-term commercial success. Success depends on a scientifically designed formulation strategy that delivers quality, stability, manufacturability, regulatory compliance, and patient value throughout the product lifecycle. A scientifically driven formulation strategy helps translate innovation into safe, effective, and commercially successful medicines. Promising Molecule [triangle-down] Scientifically...

Continue reading

Selecting the Right Drug Development Pathway: 505(b)(1) vs 505(b)(2) vs 505(j)

Which Pathway  Fits Your Product Choose the right route based on your development goal. 505(b)(1) Choose 505(b)(1) if you are developing a novel drug with a new active ingredient and need full evidence of safety and efficacy. 505(b)(2) Choose 505(b)(2) if you want to improve an existing approved drug (new formulation, dosage form, indication, or route) while leveraging existing FDA data to reduce time and cost. 505(j) Choose ANDA (505(j)) if your objective is to develop a generic equivalent that matches the reference listed drug in quality and performance. FDA Approval Paths Parameter 505(b)(1)...

Continue reading